Sign Up to like & get
recommendations!
0
Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.3010
Abstract: REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial), an event-driven trial, randomized 8,179 statin-treated patients with elevated triglycerides (TGs) and increased cardiovascular (CV) risk to icosapent ethyl (IPE); pure, stable prescription eicosapentaenoic acid, 4g/day…
read more here.
Keywords:
across prespecified;
endpoint;
safety;
efficacy ... See more keywords